MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma (Q39376558)

11 September 2017

MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma (English)

1 reference

11 September 2017

1 reference

Anthony Wing-Hung Chan

object named as

Anthony W-H Chan

3

0 references

Ka Fai To

6

object named as

Ka-Fai To

1 reference

11 September 2017

7

Nathalie Wong

1 reference

11 September 2017

Priscilla T-Y Law

1

1 reference

11 September 2017

Arthur K-K Ching

2

1 reference

11 September 2017

Queenie W-L Wong

4

1 reference

11 September 2017

Chun-Kwok Wong

5

1 reference

11 September 2017

language of work or name

English

0 references

publication date

19 March 2012

1 reference

11 September 2017

1 reference

11 September 2017

33

1 reference

11 September 2017

6

1 reference

11 September 2017

1134-1141

1 reference

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

11 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Hsa-let-7g inhibits proliferation of hepatocellular carcinoma cells by downregulation of c-Myc and upregulation of p16(INK4A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

RAS is regulated by the let-7 microRNA family

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Diagnostic and prognostic microRNAs in stage II colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Reactivation of the insulin-like growth factor-II signaling pathway in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Biological effects of human insulin receptor substrate-1 overexpression in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Overexpression of insulin receptor substrate-2 in human and murine hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

MicroRNA signatures in human ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

The colorectal microRNAome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Emerging roles of microRNA in the intracellular signaling networks of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

MicroRNA control of signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Expression and function of the insulin receptor substrate proteins in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Insulin receptor substrate 1 antisense expression in an hepatoma cell line reduces cell proliferation and induces overexpression of the Src homology 2 domain and collagen protein (SHC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Wnt signaling in disease and in development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGS130

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGS130

1 reference

11 September 2017

1 reference